tremfya #n/a
janssen pharmaceutica (pty) ltd - #n/a - see ingredients - each 1,0 ml solution contains guselkumab 100,0 mg
avastin 25mg/ml concentrate for solution for infusion
roche diagnostics gmbh - bevacizumab - concentrate for solution for infusion - 25mg/ml
avastin 25mg/ml concentrate for solution for infusion
roche diagnostics gmbh - bevacizumab - concentrate for solution for infusion - 25mg/ml
meriofert 75iu/ml pfs powder & solvent for solution for injection
meriofert 150iu/ml pfs powder & solvent for solution for injection
afinitor tablet 2.5 mg
novartis (singapore) pte ltd - everolimus +0.2% bht - tablet - 2.50 mg - everolimus +0.2% bht 2.50 mg
afinitor tablet 10mg
novartis (singapore) pte ltd - everolimus - tablet - 10.00mg - everolimus 10.00mg
afinitor tablet 5mg
novartis (singapore) pte ltd - everolimus - tablet - 5.00mg - everolimus 5.00mg
hospira methotrexate injection
pfizer new zealand limited - methotrexate 25 mg/ml (as methotrexate sodium) - solution for injection - 7.5 mg/0.3ml - active: methotrexate 25 mg/ml (as methotrexate sodium) excipient: sodium chloride sodium hydroxide water for injection - methotrexate may be of value in the symptomatic control of server, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.
soravar 200 film coated tablet 200 mg
accord healthcare private limited - sorafenib tosylate eqv to sorafenib - tablet, film coated - sorafenib tosylate eqv to sorafenib 200 mg